Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 5/2019

01-10-2019 | Research Article

Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study

Authors: Mark Møller Fastø, Natalja Genina, Susanne Kaae, Sofia Kälvemark Sporrong

Published in: International Journal of Clinical Pharmacy | Issue 5/2019

Login to get access

Abstract

Background 3D-printing, compared to conventional medicine manufacturing technologies, is a versatile and highly modifiable technique that has the flexibility to produce medicine that meet patients’ specific requirements such as individualized dosing, but also to customize the appearance of the dosage form, e.g., shape and colour. Objective To explore polypharmacy patients’ perceptions and preferences regarding 3D-printed medicine, including their acceptability of patient-designed medicine. Setting The study was conducted in Zealand, Denmark. Method Polypharmacy patients were recruited using convenience sampling (mostly on Facebook) and interviewed twice using semi-structured interviews. Interviews were analysed thematically into five predetermined themes (shapes, colours, embossing designs, polypills, and patient-designed dosage forms). At the first interview patients were asked about their perceptions and preferences towards 3D-printed solid dosage forms, and were presented to different shapes, colours, embossing designs and examples of polypills. They were also invited to design their own medicine from the ones presented. Their self-designed medicines were presented at the second interview, where acceptability of both their self-designed medicine and the concept of designing one’s own medicine, was investigated. Main outcome measure Patients’ perceptions, preferences towards and acceptability of 3D-printed medicines. Results Eight patients were included. They tended to prefer shapes similar to conventional medicine. Different colours were preferred by different people. The presented embossing designs seemed to be irrelevant. Polypills were generally believed to be a good idea due to the reduction of number of medicines. Acceptability of patient-designed medicine was mainly determined by whether patients thought 3Dprinting technology was reliable or not. Conclusions The patients had various perceptions and preferences of 3D-printed medicine. Factors affecting the patient views were aesthetic (appealing), physiological (swallowing), practical (handling), pedagogical (understanding) and psychological (relate to). Trust in the technology seemed to be important for acceptability.
Literature
1.
go back to reference Di Prima M, Coburn J, Hwang D, Kelly J, Khairuzzaman A, Ricles L. Additively manufactured medical products—the FDA perspective. 3D Print Med. 2015;2:1.CrossRef Di Prima M, Coburn J, Hwang D, Kelly J, Khairuzzaman A, Ricles L. Additively manufactured medical products—the FDA perspective. 3D Print Med. 2015;2:1.CrossRef
2.
go back to reference Lind J, Kälvemark Sporrong S, Kaae S, Rantanen J, Genina N. Social aspects in additive manufacturing of pharmaceutical products. Expert Opin Drug Deliv. 2017;14:927–36.CrossRef Lind J, Kälvemark Sporrong S, Kaae S, Rantanen J, Genina N. Social aspects in additive manufacturing of pharmaceutical products. Expert Opin Drug Deliv. 2017;14:927–36.CrossRef
3.
go back to reference Kaae S, Lind JLM, Genina N, Sporrong SK. Unintended consequences for patients of future personalized pharmacoprinting. Int J Clin Pharm. 2018;2018(40):321–4.CrossRef Kaae S, Lind JLM, Genina N, Sporrong SK. Unintended consequences for patients of future personalized pharmacoprinting. Int J Clin Pharm. 2018;2018(40):321–4.CrossRef
4.
go back to reference Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. Patient acceptability of 3D printed medicines. Int J Pharm. 2017;530:71–8.CrossRef Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit AW, Orlu M. Patient acceptability of 3D printed medicines. Int J Pharm. 2017;530:71–8.CrossRef
5.
go back to reference Scoutaris N, Ross SA, Douroumis D. 3D printed “Starmix” Drug loaded dosage forms for paediatric applications. Pharm Res. 2018;35:34.CrossRef Scoutaris N, Ross SA, Douroumis D. 3D printed “Starmix” Drug loaded dosage forms for paediatric applications. Pharm Res. 2018;35:34.CrossRef
6.
go back to reference Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015;217:308–14.CrossRef Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. J Control Release. 2015;217:308–14.CrossRef
7.
go back to reference Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm. 2015;494:643–50.CrossRef Khaled SA, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int J Pharm. 2015;494:643–50.CrossRef
8.
go back to reference Bryant L, Martini N, Chan J, Chang L, Marmoush A, Robinson B, Yu K, Wong M. Could the polypill improve adherence? The patient perspective. J Prim Health Care. 2013;5:28–35.CrossRef Bryant L, Martini N, Chan J, Chang L, Marmoush A, Robinson B, Yu K, Wong M. Could the polypill improve adherence? The patient perspective. J Prim Health Care. 2013;5:28–35.CrossRef
9.
go back to reference Williams B, Shaw A, Durrant R, Crinson I, Pagliari C, de Lusignan S. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM Int J Med. 2005;98:885–93.CrossRef Williams B, Shaw A, Durrant R, Crinson I, Pagliari C, de Lusignan S. Patient perspectives on multiple medications versus combined pills: a qualitative study. QJM Int J Med. 2005;98:885–93.CrossRef
10.
go back to reference Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80:808–17.CrossRef Saedder EA, Lisby M, Nielsen LP, Bonnerup DK, Brock B. Number of drugs most frequently found to be independent risk factors for serious adverse reactions: a systematic literature review. Br J Clin Pharmacol. 2015;80:808–17.CrossRef
11.
go back to reference Aho J, Bøtker JP, Genina N, Edinger M, Arnfast L, Rantanen J. Roadmap to 3D-printed oral pharmaceutical dosage forms: feedstock filament properties and characterization for fused deposition modeling. J Pharm Sci. 2019;108:26–35.CrossRef Aho J, Bøtker JP, Genina N, Edinger M, Arnfast L, Rantanen J. Roadmap to 3D-printed oral pharmaceutical dosage forms: feedstock filament properties and characterization for fused deposition modeling. J Pharm Sci. 2019;108:26–35.CrossRef
12.
go back to reference Smith DM, Kapoor Y, Klinzing GR, Procopio AT. Pharmaceutical 3D printing: design and qualification of a single step print and fill capsule. Int J Pharm. 2018;544:21–30.CrossRef Smith DM, Kapoor Y, Klinzing GR, Procopio AT. Pharmaceutical 3D printing: design and qualification of a single step print and fill capsule. Int J Pharm. 2018;544:21–30.CrossRef
13.
go back to reference Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends Pharmacol Sci. 2018;2018(39):440–51.CrossRef Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D Printing Pharmaceuticals: Drug Development to Frontline Care. Trends Pharmacol Sci. 2018;2018(39):440–51.CrossRef
15.
go back to reference Kvale S, Brinkmann S. Interview: det kvalitative forskningsinterview som håndværk. Copenhagen: Hans Reitzels Forlag; 2015. Kvale S, Brinkmann S. Interview: det kvalitative forskningsinterview som håndværk. Copenhagen: Hans Reitzels Forlag; 2015.
16.
go back to reference Robson C. Real world research. 3rd ed. Hoboken: Wiley; 2011. Robson C. Real world research. 3rd ed. Hoboken: Wiley; 2011.
17.
go back to reference Marquis J, Schneider M-P, Payot V, Cordonier C, Bugnon O, Hersberger KE, Arnet I. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013;35:1130–6.CrossRef Marquis J, Schneider M-P, Payot V, Cordonier C, Bugnon O, Hersberger KE, Arnet I. Swallowing difficulties with oral drugs among polypharmacy patients attending community pharmacies. Int J Clin Pharm. 2013;35:1130–6.CrossRef
18.
go back to reference Liu F, Ghaffur A, Bains J, Hamdy S. Acceptability of oral solid medicines in older adults with and without dysphagia: a nested pilot validation questionnaire based observational study. Int J Pharm. 2016;512:374–81.CrossRef Liu F, Ghaffur A, Bains J, Hamdy S. Acceptability of oral solid medicines in older adults with and without dysphagia: a nested pilot validation questionnaire based observational study. Int J Pharm. 2016;512:374–81.CrossRef
19.
Metadata
Title
Perceptions, preferences and acceptability of patient designed 3D printed medicine by polypharmacy patients: a pilot study
Authors
Mark Møller Fastø
Natalja Genina
Susanne Kaae
Sofia Kälvemark Sporrong
Publication date
01-10-2019
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 5/2019
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-019-00892-6

Other articles of this Issue 5/2019

International Journal of Clinical Pharmacy 5/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.